News | Radiation Dose Management | February 28, 2017

ACR Updates Guidelines for NEMA XR-29 CT Dose Standard

Document states Medic Vision’s SafeCT-29 is the only FDA- and CMS-approved third-party vendor XR-29 upgrade product

ACR, guideline update, NEMA XR-29 Smart Dose Standard, Medic Vision, SafeCT-29

February 28, 2017 — The American College of Radiology (ACR) published updated guidelines regarding the NEMA XR-29 (MITA Smart Dose) Standard, finally setting a clear and specific set of guidelines for an acceptable Certificate of NEMA XR-29 Compliance. The publication specifically declares, "certificates of NEMA XR-29 Compliance from third-party vendors are acceptable if: (1) The third-party vendor has obtained the required FDA [U.S. Food and Drug Administration] 510(K) pre-market clearance for their upgrade product; and (2) The third-party vendor upgrade product has been approved by CMS [Centers for Medicare and Medicaid Services]."

Furthermore, the document states, "Currently, the only FDA- and CMS-approved third-party vendor NEMA XR-29 upgrade product is the Medic Vision SafeCT-29."

The SafeCT-29 system is an add-on system that helps achieve compliance with the XR-29 Standard for computed tomography (CT) and positron emission tomography (PET)/CT systems equipped with automatic exposure control (AEC) and Reference protocols. SafeCT-29 provides the XR-29 Dose Check and RDSR functions. It is the first and only FDA 510k-cleared third-party solution on the market, according to Medic vision.

The timing of this guideline announcement is critical, according to Medic Vision, as CMS penalties for non-compliance triple this year. Health institutes that did not receive OEM support for XR-29 compliance and did not purchase SafeCT-29 as a third-party FDA-cleared solution for CT and PET/CT scanners, may now have to start over and potentially be subject to the 15 percent CMS penalty, which went into effect on Jan. 1, 2017.

For more information: www.medicvision.com


Related Content

News | Computed Tomography (CT)

July 16, 2024 — Arineta, a leader in advancing cardiovascular imaging solutions through cutting-edge technology, proudly ...

Home July 16, 2024
Home
News | Computed Tomography (CT)

May 1, 2024 —In this 3-stage study, 3 cohorts were used for diagnostic performance, and prognostic performance ...

Home May 01, 2024
Home
News | Computed Tomography (CT)

April 22, 2024 — A new study showed that a non-invasive imaging test can help identify patients with coronary artery ...

Home April 22, 2024
Home
Feature | Computed Tomography (CT) | By Alberto Morales, MD

Cardiac CT scans, recommended by the American College of Cardiology (ACC) and the American Heart Association (AHA) as ...

Home March 20, 2024
Home
News | Computed Tomography (CT)

February 20, 2024 — Ultrahigh-spatial-resolution photon-counting detector CT improved assessment of coronary artery ...

Home February 20, 2024
Home
News | Computed Tomography (CT)

HeartFlow is offering a free webinar based on a recent study that measured the ability of the of its roadmap analysis to ...

Home January 15, 2024
Home
News | Computed Tomography (CT)

December 19, 2023 — Siemens Healthineers announced the Food and Drug Administration (FDA) clearance of the Somatom Pro ...

Home December 19, 2023
Home
Feature | Computed Tomography (CT) | By Andrew Michalski, PhD and Rohit Sood MD, PhD

Coronary artery disease (CAD), also known as ischemic heart disease, is the most common heart disease with a prevalence ...

Home December 05, 2023
Home
News | Computed Tomography (CT)

October 26, 2023 — HeartFlow, Inc., a leader in non-invasive integrated artificial intelligence (AI) heart care ...

Home October 26, 2023
Home
News | Computed Tomography (CT)

October 13, 2023 — Arineta Cardiac Imaging is excited to announce the FDA 510(k) clearance of the SpotLight and ...

Home October 13, 2023
Home
Subscribe Now